Zoetis Inc.
Financial highlights
| Metric | FY 12/31/25 | FY 12/31/24 | FY 12/31/23 | FY 12/31/22 | FY 12/31/21 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $9.5B | $9.3B | $8.5B | $8.1B | $7.8B |
| Cost of revenue | $2.7B | $2.7B | $2.6B | $2.5B | $2.3B |
| Selling, general & administrative | $2.4B | $2.3B | $2.2B | $2.0B | $2.0B |
| Research and development | $698.0M | $686.0M | $614.0M | $539.0M | $508.0M |
| Interest expense | $222.0M | $225.0M | $239.0M | $221.0M | $224.0M |
| Pretax income | $3.4B | $3.1B | $2.9B | $2.7B | $2.5B |
| Income tax expense | $687.0M | $637.0M | $596.0M | $545.0M | $454.0M |
| Net income | $2.7B | $2.5B | $2.3B | $2.1B | $2.0B |
| Balance Sheet | |||||
| Current assets | $6.8B | $6.0B | $6.3B | $7.5B | $6.9B |
| Total assets | $15.5B | $14.2B | $14.3B | $14.9B | $13.9B |
| Current liabilities | $2.2B | $3.4B | $1.9B | $3.2B | $1.8B |
| Total liabilities | $12.1B | $9.5B | $9.3B | $10.5B | $9.4B |
| Total debt | $9.2B | $6.7B | $6.7B | $8.0B | $6.7B |
| Stockholders' equity | $3.3B | $4.8B | $5.0B | $4.4B | $4.5B |
| Cash Flow Statement | |||||
| Cash from operations | $2.9B | $3.0B | $2.4B | $1.9B | $2.2B |
| Depreciation and amortization | $487.0M | $497.0M | $491.0M | $465.0M | $448.0M |
| Stock-based compensation | $83.0M | $74.0M | $60.0M | $62.0M | $58.0M |
| Capital expenditure | $621.0M | $655.0M | $732.0M | $586.0M | $477.0M |
| Free cash flow | $2.3B | $2.3B | $1.6B | $1.3B | $1.7B |
| Dividends paid | $897.0M | $812.0M | $716.0M | $631.0M | $509.0M |
| Share repurchases | $3.2B | $1.9B | $1.1B | $1.6B | $743.0M |
| Impairments | $47.0M | $31.0M | $46.0M | $53.0M | $47.0M |
Shares outstanding 419.2M · Free float 94.4%
Annual filing data through FY ended December 31, 2025; float as of July 14, 2026.
Recent filings
- May 22, 2026 8-K
- May 20, 2026 8-K
- May 7, 2026 10-Q
- May 7, 2026 8-K
- February 12, 2026 10-K
- February 12, 2026 8-K
- February 5, 2026 8-K
- December 18, 2025 8-K